YOU ARE HERE:
Half of all new HIV infections could be averted if proven prevention efforts expanded
A new report suggests that 50% of projected HIV infections by 2015 could be prevented if governments and donors increase their HIV expenditure to UNAIDS target levels and implement prevention programmes that have been proven to work.
The Global HIV Prevention Working Group’s report, Bringing HIV Prevention to Scale: An Urgent Global Priority, shows that prevention efforts are not keeping pace with expanding access to antiretroviral therapy. For every person who started effective anti-HIV treatment in 2006, six become newly infected with the virus.
It is estimated that there will be 60 million new HIV infections by 2015, but the report suggests that 30 million of these could be avoided if scientifically proven methods of HIV prevention were implemented.
These measures include treatment to prevent mother-to-child transmission of HIV; testing; prevention efforts targeted at high risk groups, such as men who have sex with men and sex workers; and male circumcision.
However, the working group point to evidence showing that few people who would benefit from HIV prevention have access to it. This includes access to interventions that have been scientifically proven to significantly reduce the risk of HIV transmission, for example:
Although the report suggests that male circumcision could help reduce new HIV infections by 8% by 2015, it warns that no single prevention intervention can be 100% effective.
There has been a significant increase in global HIV spending in recent years, with projected spending in 2007 being $10 billion. However, the working group says that to make a real difference expenditure needs to more than double over the next three years to reach the UNAIDS target of $22 billion by 2010. Effective prevention would account for half of this money.
Membership of the working group includes public health experts, doctors, scientific researchers and people with HIV. It is jointly convened by the Henry J Kaiser Family Foundation and the Bill & Melinda Gates Foundation.
The Global HIV Prevention Working Group’s report, Bringing HIV Prevention to Scale: An Urgent Global Priority, shows that prevention efforts are not keeping pace with expanding access to antiretroviral therapy. For every person who started effective anti-HIV treatment in 2006, six become newly infected with the virus.
It is estimated that there will be 60 million new HIV infections by 2015, but the report suggests that 30 million of these could be avoided if scientifically proven methods of HIV prevention were implemented.
These measures include treatment to prevent mother-to-child transmission of HIV; testing; prevention efforts targeted at high risk groups, such as men who have sex with men and sex workers; and male circumcision.
However, the working group point to evidence showing that few people who would benefit from HIV prevention have access to it. This includes access to interventions that have been scientifically proven to significantly reduce the risk of HIV transmission, for example:
- Prevention of mother-to-child transmission – in low- and middle-income countries in 2005, only 11% of HIV-positive pregnant women had access to cheap treatment shown to dramatically reduce the risks of vertical transmission.
- HIV testing – only 12% of men and 10% of women in the African countries most seriously affected by HIV had had an HIV test.
- High-risk groups – prevention efforts reached only 9% of men who have sex with men, 8%of injecting drug users, and less than a fifth of sex workers in 2005. Many government still opt for general HIV awareness campaigns rather than initiatives targeted at the groups most at risk of infection.
Although the report suggests that male circumcision could help reduce new HIV infections by 8% by 2015, it warns that no single prevention intervention can be 100% effective.
There has been a significant increase in global HIV spending in recent years, with projected spending in 2007 being $10 billion. However, the working group says that to make a real difference expenditure needs to more than double over the next three years to reach the UNAIDS target of $22 billion by 2010. Effective prevention would account for half of this money.
Membership of the working group includes public health experts, doctors, scientific researchers and people with HIV. It is jointly convened by the Henry J Kaiser Family Foundation and the Bill & Melinda Gates Foundation.
aidsmap resources
Africa news
- Africa: AIDS hits health services
- India legalises sex between men
- Scale up of early infant diagnosis in rural Ethiopia successful
Asia and Pacific news
- India legalises sex between men
- World Bank: Financial crisis threatens HIV treatment for 1.7 million
- Gates Foundation to fund trial of lower efavirenz dose
Developed world news
- Similar rises in gay men’s HIV diagnoses seen in Western Europe, North America and Australia since 2000
- Treatment as prevention rejected by French ministry of health
- French ‘treatment as prevention’ statement urges campaign on benefits of HIV testing and treatment, but cautions against compulsory testing
Eastern Europe and Russia news
- World Bank: Financial crisis threatens HIV treatment for 1.7 million
- HIV diagnoses in European MSM have almost doubled since 2000, UK tops the list
- Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains
HIV and drug use news
- Study shows clear association between use of multiple drugs and risk of HIV for gay men
- Average viral load in the community predicts HIV incidence in drug users
- New UN drug policy will undermine HIV prevention
HIV and sexual health news
- HIV-positive gay men in UK still disproportionately affected by syphilis and LGV
- Detectable viral load means risk of superinfection for long-term HIV-positive couples
- LGV - it's here to stay
Latin America news
- Taking HIV treatment before conception increases risk of having a premature or low weight baby, Brazilian study shows
- CD4 cell count increases sustained up to five years in developing-world treatment programmes
- Brazil rejects tenofovir patent
Middle East news
feedback
Give us your views on our work
